Annual Retained Earnings
-$560.90 M
-$98.79 M-21.38%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual retained earnings is -$560.90 million, with the most recent change of -$98.79 million (-21.38%) on December 31, 2023.
- During the last 3 years, RLMD annual retained earnings has fallen by -$381.59 million (-212.80%).
- RLMD annual retained earnings is now -4635459.50% below its all-time high of -$12.10 thousand, reached on August 31, 2012.
Performance
RLMD Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$622.22 M
-$21.73 M-3.62%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly retained earnings is -$622.22 million, with the most recent change of -$21.73 million (-3.62%) on September 30, 2024.
- Over the past year, RLMD quarterly retained earnings has dropped by -$39.49 million (-6.78%).
- RLMD quarterly retained earnings is now -5142254.55% below its all-time high of -$12.10 thousand, reached on August 31, 2012.
Performance
RLMD Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RLMD Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.4% | -6.8% |
| 3 y3 years | -212.8% | -129.9% |
| 5 y5 years | -402.3% | -439.5% |
RLMD Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.9% | at low | -104.0% | at low |
| 5 y | 5-year | -368.0% | at low | -439.5% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Relmada Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$622.22 M(+3.6%) |
| Jun 2024 | - | -$600.50 M(+3.0%) |
| Mar 2024 | - | -$582.73 M(+3.9%) |
| Dec 2023 | -$560.90 M(+21.4%) | -$560.90 M(+4.7%) |
| Sep 2023 | - | -$535.74 M(+4.3%) |
| Jun 2023 | - | -$513.74 M(+5.2%) |
| Mar 2023 | - | -$488.43 M(+5.7%) |
| Dec 2022 | -$462.11 M(+51.5%) | -$462.11 M(+8.9%) |
| Sep 2022 | - | -$424.17 M(+10.2%) |
| Jun 2022 | - | -$384.75 M(+11.6%) |
| Mar 2022 | - | -$344.81 M(+13.0%) |
| Dec 2021 | -$305.07 M(+70.1%) | -$305.07 M(+12.7%) |
| Sep 2021 | - | -$270.69 M(+18.7%) |
| Jun 2021 | - | -$228.08 M(+13.2%) |
| Mar 2021 | - | -$201.53 M(+12.4%) |
| Dec 2020 | -$179.32 M(+49.6%) | -$179.32 M(+13.1%) |
| Sep 2020 | - | -$158.55 M(+11.9%) |
| Jun 2020 | - | -$141.65 M(+8.5%) |
| Mar 2020 | - | -$130.53 M(+13.2%) |
| Dec 2019 | -$119.86 M(+7.3%) | - |
| Sep 2019 | - | -$115.33 M(+3.3%) |
| Jun 2019 | -$111.66 M | -$111.66 M(+3.8%) |
| Mar 2019 | - | -$107.54 M(+2.6%) |
| Dec 2018 | - | -$104.85 M(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$97.72 M(+3.6%) |
| Jun 2018 | -$94.34 M(+10.5%) | -$94.34 M(+3.7%) |
| Mar 2018 | - | -$90.99 M(+3.6%) |
| Dec 2017 | - | -$87.79 M(+1.7%) |
| Sep 2017 | - | -$86.37 M(+1.1%) |
| Jun 2017 | -$85.38 M(+7.9%) | -$85.38 M(+2.0%) |
| Mar 2017 | - | -$83.75 M(+2.4%) |
| Dec 2016 | - | -$81.77 M(+1.3%) |
| Sep 2016 | - | -$80.74 M(+2.1%) |
| Jun 2016 | -$79.10 M(+3.9%) | -$79.10 M(+4.4%) |
| Mar 2016 | - | -$75.78 M(+2.5%) |
| Dec 2015 | - | -$73.92 M(+3.4%) |
| Sep 2015 | - | -$71.46 M(-6.1%) |
| Jun 2015 | -$76.12 M(+37.6%) | -$76.12 M(-7.4%) |
| Mar 2015 | - | -$82.16 M(+3.1%) |
| Dec 2014 | - | -$79.70 M(-6.4%) |
| Sep 2014 | - | -$85.16 M(>+9900.0%) |
| Jun 2014 | -$55.32 M(>+9900.0%) | - |
| Feb 2014 | - | -$74.70 K(+4.5%) |
| Nov 2013 | - | -$71.50 K(+25.0%) |
| Aug 2013 | -$57.20 K(+372.7%) | -$57.20 K(+27.7%) |
| May 2013 | - | -$44.80 K(+77.1%) |
| Feb 2013 | - | -$25.30 K(+109.1%) |
| Aug 2012 | -$12.10 K | -$12.10 K |
FAQ
- What is Relmada Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Relmada Therapeutics?
- What is Relmada Therapeutics annual retained earnings year-on-year change?
- What is Relmada Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly retained earnings year-on-year change?
What is Relmada Therapeutics annual retained earnings?
The current annual retained earnings of RLMD is -$560.90 M
What is the all time high annual retained earnings for Relmada Therapeutics?
Relmada Therapeutics all-time high annual retained earnings is -$12.10 K
What is Relmada Therapeutics annual retained earnings year-on-year change?
Over the past year, RLMD annual retained earnings has changed by -$98.79 M (-21.38%)
What is Relmada Therapeutics quarterly retained earnings?
The current quarterly retained earnings of RLMD is -$622.22 M
What is the all time high quarterly retained earnings for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly retained earnings is -$12.10 K
What is Relmada Therapeutics quarterly retained earnings year-on-year change?
Over the past year, RLMD quarterly retained earnings has changed by -$39.49 M (-6.78%)